YC W24
SynsoryBio
"If-then" conditional logic for protein drugs
About
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Founders
- Nathan Tague
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in SynsoryBio.
See family office activityIndustry & Focus
HealthcareTherapeuticsSynthetic BiologyBiotechOncology